Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Novartis AG ADS
(NY:
NVS
)
73.12
USD
-0.17 (-0.23%)
Official Closing Price
/ Updated:
4:15 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Blog posts about Novartis AG ADS
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
One Reason Novartis is Expected to Overtake Pfizer in Revenue: its Generics Business
October 16, 2012
category
NVS
,
SNY
,
GSK
, and 1 more.
from
YCharts
Golly, Big Pharma, This Emerging Markets Strategy Isn’t Looking So Easy, Is It?
October 16, 2012
category
NVS
,
MRK
,
GSK
, and 2 more.
from
YCharts
(ARIA) ARIAD Pharmaceuticals Seeks Ponatinib Approval
October 10, 2012
ARIAD Pharmaceuticals, Inc. (ARIA) recently completed the rolling submission of the New Drug... Visit StockBlogHub to view complete post.
Read More
category
Biotechnology
,
Ariad Pharmaceuticals Inc
,
NVS
, and 13 more.
from
Stock Blog Hub
(MYL) More Generic Launches at Mylan
October 09, 2012
Mylan Pharmaceuticals Inc., a subsidiary of Mylan Inc. (MYL), recently announced that it has... Visit StockBlogHub to view complete post.
Read More
category
Mylan Inc/
,
Dr/ Reddy's Laboratories Limited
,
TEVA
, and 9 more.
from
Stock Blog Hub
(RDY) Generic Launch at Dr. Reddy’s Laboratories
October 09, 2012
Dr. Reddy’s Laboratories (RDY) recently announced the launch of its generic version of Merck &... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
Dr/ Reddy's Laboratories Limited
,
Novartis AG
, and 9 more.
from
Stock Blog Hub
(NVS) Novartis’ Votubia Earns Positive Comments from Committee for Medicinal Products for Human Use
October 09, 2012
Switzerland-based pharmaceutical company, Novartis AG (NVS) recently announced that the Committee... Visit StockBlogHub to view complete post.
Read More
category
AZN
,
Onyx Pharmaceuticals Inc
,
Stephan Company
, and 11 more.
from
Stock Blog Hub
(PFS) Bayer’s Stivarga Gains Approval
October 09, 2012
The HealthCare unit of Bayer (BAYRY) recently announced that the US Food and Drug Administration... Visit StockBlogHub to view complete post.
Read More
category
Onyx Pharmaceuticals Inc
,
Sanofi/Aventis
,
Novartis AG
, and 9 more.
from
Stock Blog Hub
Big Pharma’s Push Into Emerging Markets Meets More Resistance: “Unwarranted” Patents Targeted
October 09, 2012
category
NVS
,
GSK
,
ABT
from
YCharts
(JNJ) Shire Aims to Expand Vyvanse Label
October 08, 2012
Shire plc (SHPG) recently announced that the US Food and Drug Administration (FDA) has accepted the... Visit StockBlogHub to view complete post.
Read More
category
Watson Pharmaceuticals Inc/
,
Mylan Inc/
,
JNJ
, and 7 more.
from
Stock Blog Hub
Attention Value Shoppers: Deals in the Euro Aisle
October 01, 2012
category
FEZ
,
TOT
,
BP
, and 5 more.
from
YCharts
A Big Part of the Pharma Pipeline is Struggling: Biotech Startups
September 25, 2012
category
NVS
,
AZN
,
MRK
, and 4 more.
from
YCharts
Delays for India’s Ranbaxy Good News for Novartis and its $5.7 Billion Drug, Diovan
September 25, 2012
category
NVS
,
MYL
from
YCharts
Novartis Booked a New High
September 25, 2012
New York, September 25th (TradersHuddle.com) - Shares of Novartis AG ( NYSE:NVS ) booked a new 52 week high today by trading above $61.5, traders are definitely monitoring Novartis' price action to see...
Read More
from
TradersHuddle.com
More Upside for Novartis ?
September 24, 2012
New York, September 24th (TradersHuddle.com) - Shares of Novartis AG ( NYSE:NVS ) booked a new 52 week high today by trading above $61.42, traders are definitely monitoring Novartis' price action to...
Read More
from
TradersHuddle.com
A 52 Week High for Novartis, will it Hold?
September 21, 2012
New York, September 21st (TradersHuddle.com) - Shares of Novartis AG ( NYSE:NVS ) booked a new 52 week high today by trading above $60.65, traders are definitely monitoring Novartis' price action to...
Read More
from
TradersHuddle.com
High Above Average Volume on Novartis
September 19, 2012
New York, September 19th (TradersHuddle.com) - Unusual high volume detected on shares of Novartis AG ( NYSE:NVS ) early in the trading session. The pace in volume of Novartis is already above average,...
Read More
from
TradersHuddle.com
Pfizer-Hisun JV Launched – Analyst Blog
September 18, 2012
Pfizer (PFE) and Chinese pharmaceutical company, Zhejiang Hisun Pharmaceuticals, recently announced the launch of their joint venture (JV) – Hisun-Pfizer Pharmaceuticals Co., Ltd. The joint venture,...
Read More
category
Zacks
,
Syndicated Content
from
Money Morning
The Cooper Companies – Momentum
September 18, 2012
The Cooper Companies (COO) delivered a 12.4% earnings surprise in the third quarter of fiscal 2012 (ended July 31) and raised guidance for the year. Moreover, this leading contact lens provider has now...
Read More
category
Zacks
,
Syndicated Content
from
Money Morning
Upgrades & Downgrades
September 17, 2012
New York, September 17th (TradersHuddle.com) – Following are some of the upgrades and downgrades before the market open. AK Steel (NYSE: AKS ) was do. Read More --
Read More
from
TradersHuddle.com
Biotech Sanofi (NYSE: SNY) Receives Drug Approval
September 14, 2012
Sanofi's multiple sclerosis drug can now tap the $12 billion U.S. market...
Read More
from
Wealth Daily
(RDY) Dr. Reddy’s Laboratories Launches Generic Toprol
September 13, 2012
Dr. Reddy’s Laboratories (RDY) recently announced the launch of its generic version of... Visit StockBlogHub to view complete post.
Read More
category
Par Pharmaceutical Companies Inc
,
Mylan Inc/
,
Glaxosmithkline plc
, and 17 more.
from
Stock Blog Hub
Yet Another Problem for U.S. Pharma Companies Seeking Growth in Emerging Markets
September 06, 2012
category
NVS
from
YCharts
This Drugmaker Can't Seem To Shake Its Manufacturing Problems
September 05, 2012
category
NVS
,
SNY
,
JNJ
from
YCharts
(ARIA) ARIAD Pharmaceuticals Seeks European Medicines Agency Nod for Ponatinib
September 03, 2012
ARIAD Pharmaceuticals, Inc. (ARIA) recently submitted a Marketing Authorization Application (MAA)... Visit StockBlogHub to view complete post.
Read More
category
Biotechnology
,
Ariad Pharmaceuticals Inc
,
Novartis AG
, and 9 more.
from
Stock Blog Hub
(HRS) Harris Wins Major Order
August 30, 2012
Harris Corporation (HRS), a leader in the public safety and professional communication market, has... Visit StockBlogHub to view complete post.
Read More
category
MSI
,
Harris Corporation
,
FAA
, and 13 more.
from
Stock Blog Hub
(ALNY) Alnylam Pharmaceuticals and Monsanto Collaborate
August 30, 2012
Alnylam Pharmaceuticals, Inc. (ALNY) and Monsanto Company (MON) recently formed a strategic... Visit StockBlogHub to view complete post.
Read More
category
MON
,
Biotechnology
,
MDT
, and 13 more.
from
Stock Blog Hub
Prestige Brands – Value
August 29, 2012
Earnings momentum for Prestige Brands Holdings, Inc. (PBH) has been gaining since this over-the-counter healthcare and household cleaning products company reported strong fiscal first quarter results....
Read More
category
Zacks
,
Syndicated Content
from
Money Morning
High Above Average Volume on Novartis
August 22, 2012
New York, August 22nd (TradersHuddle.com) - Unusual high volume detected on shares of Novartis AG ( NYSE:NVS ) early in the trading session. The pace in volume of Novartis points to a break above...
Read More
from
TradersHuddle.com
More Upside for Novartis ?
August 22, 2012
New York, August 22nd (TradersHuddle.com) - Shares of Novartis AG ( NYSE:NVS ) booked a new 52 week high today by trading above $60.62, traders are definitely monitoring Novartis' price action to see...
Read More
from
TradersHuddle.com
(ALNY) Alnylam Pharmaceuticals Earns Milestone Payment
August 21, 2012
Alnylam Pharmaceuticals Inc. (ALNY) recently earned development milestone payment of $3.2 million... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
Biotechnology
,
MDT
, and 11 more.
from
Stock Blog Hub
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here